Trexquant Investment LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,180,713
-44.8%
30,933
-27.5%
0.03%
-56.0%
Q3 2022$2,140,000
+38.2%
42,638
+10.4%
0.08%
+8.7%
Q2 2022$1,548,000
+59.3%
38,633
+48.2%
0.07%
+50.0%
Q1 2022$972,000
+328.2%
26,060
+358.2%
0.05%
+228.6%
Q4 2021$227,000
-14.7%
5,687
-20.4%
0.01%
-33.3%
Q3 2021$266,000
-13.4%
7,148
-1.4%
0.02%
-19.2%
Q2 2021$307,000
-51.3%
7,252
-46.3%
0.03%
-36.6%
Q3 2020$631,000
+132.8%
13,506
+122.3%
0.04%
+105.0%
Q1 2020$271,000
-62.0%
6,076
-59.0%
0.02%
-52.4%
Q4 2019$713,000
+21.3%
14,837
+13.5%
0.04%
-20.8%
Q2 2019$588,000
+97.3%
13,075
+65.3%
0.05%
+152.4%
Q1 2019$298,000
-74.0%
7,909
-67.6%
0.02%
-75.6%
Q3 2018$1,147,000
-49.4%
24,409
-63.7%
0.09%
-45.2%
Q2 2018$2,268,000
+431.1%
67,226
+71.6%
0.16%
+130.9%
Q4 2016$427,000
+84.1%
39,181
+8.5%
0.07%
+151.9%
Q1 2016$232,000
-92.1%
36,096
-67.3%
0.03%
-89.4%
Q3 2015$2,949,000
+93.1%
110,461
+340.1%
0.25%
+62.8%
Q1 2015$1,527,000
+316.1%
25,100
+253.5%
0.16%
+140.0%
Q4 2014$367,0007,1000.06%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ayer Capital Management, LP 416,666$7,153,00038.92%
Novo Holdings A/S 747,359$11,210,0002.78%
Bain Capital Public Equity Management, LLC 2,333,333$50,073,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 845,027$18,134,0000.84%
HealthCor Management, L.P. 732,200$15,713,0000.84%
RA Capital Management 300,000$6,438,0000.67%
Catalyst Capital Advisors LLC 30,666$658,0000.36%
CR Intrinsic Investors, LLC 119,237$2,559,0000.08%
Weiss Multi-Strategy Advisers LLC 284,130$6,098,0000.07%
SECTORAL ASSET MANAGEMENT INC 57,519$1,234,0000.06%
View complete list of PTC THERAPEUTICS INC shareholders